Press Release

Atentiv Inc. Secures $8M Financing to Advance Product Applications to Commercialization and Appoints New Members to Board of Directors

Cambridge, Mass. [April 4, 2013] – Atentiv Inc., a company providing consumers, educators, payers and clinicians with digital learning applications for children and adults, today announced it has closed an additional $8 million round of financing. The funds will be used to advance its proprietary technology platform™ the Atentiv™ System— to market.

Unlike any other learning system, the Atentiv™ System utilizes noninvasive direct brain-to-computer wireless connection that enables simple and practical training of new attention skills, personalized to the user. Initial product applications are designed to optimize attention skills in elementary and high school children, and early research suggests the technology is a novel potential treatment option for children suffering from attention-deficit/hyperactivity disorder (ADHD).

“This financing is recognition of the strength of our technology platform to address attention dysfunction in children and adults. Ongoing clinical studies at two centers in Massachusetts are fully enrolled and early data reinforces what we’ve seen to date™that the Atentiv™ System has the potential to transform the field of behavioral disorders and brain science,” said Eric Gordon, founder, chairman and CEO of Atentiv, Inc. “We look forward to launching additional studies in prominent school systems and educational centers in the United States and Singapore later this year as part of our run-up to product launch.”

Atentiv also announced today that it has appointed three new members to the company’s Board of Directors™James T. Bartlett, private investor; Marcia A. Kean, Chairman, Strategic Initiatives, Feinstein Kean Healthcare; and Ernest H. Pomerantz, Chairman, StoneWater Capital. With these additions, the Board of Directors now consists of five members, including Robert Taber, Ph.D., Senior Advisor to the Chancellor for Global Strategies, Duke University Medical Center and Eric Gordon, Founder, Chairman and CEO, Atentiv, Inc.

Commenting on the appointments, Eric Gordon said, “We are very pleased to add the deep experience and industry knowledge of these three respected individuals to our Board. We look forward to their contributions as we continue to develop and advance personalized educational tools to improve personal productivity.”

About the Atentiv™ System

The Atentiv™ System is a novel, non-pharmaceutical, digital cognitive therapy platform that delivers sustained and measurable improvements in attention control for individuals. The system leverages a proprietary, non-invasive direct brain-to-computer interface to measure a user’s unique ‘cognitive signature’. Initial product applications are designed to optimize attention skills in elementary and high school children. Other customized applications in development include memory, reasoning, multitasking and for such disorders as Alzheimer’s disease.

About Atentiv Incorporated:

Atentiv Inc. is a privately held company providing consumers, educators, payers and clinicians with digital learning applications for children and adults. Based in Cambridge, MA, the company specializes in delivering personalized, non-pharmacologic, digital learning systems to improve cognitive function in children and adults.

Media Contact for Atentiv:

Kerry Littmann: 617-761-6794
kerry.littmann@fkhealth.com

For Business Development Contact:

Eric Gordon: 508-954-0494
eric_gordon@atentiv.com
Website: www.atentiv.com